Modelling the evolution of genetic instability during tumour progression
Version of Record online: 26 NOV 2012
© 2012 The Authors. Evolutionary Applications published by Blackwell Publishing Ltd.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Special Issue: Evolution and Cancer
Volume 6, Issue 1, pages 20–33, January 2013
How to Cite
S. Datta, R., Gutteridge, A., Swanton, C., Maley, C. C. and Graham, T. A. (2013), Modelling the evolution of genetic instability during tumour progression. Evolutionary Applications, 6: 20–33. doi: 10.1111/eva.12024
- Issue online: 21 JAN 2013
- Version of Record online: 26 NOV 2012
- Manuscript Accepted: 28 SEP 2012
- Manuscript Received: 5 SEP 2012
- 2009. Genome evolution and adaptation in a long-term experiment with Escherichia coli. Nature 461:1243–1247. , , , , , , et al.
- 2009. Mutator mutations enhance tumorigenic efficiency across fitness landscapes. PLoS ONE 4:e5860.
- 2010. Efficiency of carcinogenesis: is the mutator phenotype inevitable? Seminars in Cancer Biology 20:340–352.
- 2005. Negative clonal selection in tumor evolution. Genetics 171:2123–2131. , and
- 2006. Efficiency of carcinogenesis with and without a mutator mutation. Proceedings of National Academy of Science of the United States of America 103:14140–14145. , and
- 2007. Genetic progression and the waiting time to cancer. PLoS Computational Biology 3:e225. , , , , , , et al.
- 2011. Paradoxical relationship between chromosomal instability and survival outcome in cancer. Cancer Research 71:3447–3452. , , , , , , et al.
- 2008. Genetic instability is not a requirement for tumor development. Cancer Research 68:3558–3560; discussion 3560-1. , , and
- 2010. Accumulation of driver and passenger mutations during tumor progression. Proceedings of the National Academy of Sciences of the United States of America 107(43):18545–50. , , , , , , et al.
- 1999. Genetic instability and darwinian selection in tumours. Trends in Cell Biology 9:M57–M60. , , , and
- 2011. Intratumor heterogeneity in evolutionary models of tumor progression. Genetics 188:461–477. , , , , and
- 2011. Molecular genetics of colorectal cancer. Annual Review of Pathology: Mechanisms of Disease 6:479–507.
- 2001. Mutations in the APC tumour suppressor gene cause chromosomal instability. Nature Cell Biology 3:433–438. , , , , , , et al.
- 2012. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. New England Journal of Medicine 366:883–892. , , , , , , et al.
- 2007. What can we learn from the population incidence of cancer? Armitage and Doll revisited. The lancet oncology 8:1030–1038. , , and
- 2004. The optimal rate of chromosome loss for the inactivation of tumor suppressor genes in cancer. Proceedings of National Academy of Science of the United States of America 101:7017–7021. , and
- 2008. Selective pressures for and against genetic instability in cancer: a time-dependent problem. Journal of the Royal Society, Interface 5:105–121. , , and
- 2000. Adenomatous polyposis coli (APC) mutations are sufficient for the growth of early colorectal adenomas. Proceedings of the National Academy of Sciences of the United States of America 97:2225–2228. , , , , , , et al.
- 2011. Chromosomal instability confers intrinsic multidrug resistance. Cancer Research 71:1858–1870. , , , , , , et al.
- 2001. A mutator phenotype in cancer. Cancer Research 61:3230–3239.
- 2011. Human cancers express mutator phenotypes: origin, consequences and targeting. Nature Reviews Cancer 11:450–457.
- 2002. Multistage carcinogenesis and the incidence of colorectal cancer. Proceedings of the National Academy of Sciences of the United States of America 99:15095–15100. , and
- 2000. Exploring the relationship between neutral and selective mutations in cancer. Artificial Life 6:325–345. , and
- 2004. The combination of genetic instability and clonal expansion predicts progression to esophageal adenocarcinoma. Cancer Research 64:7629–7633. , , , , , , and
- 2006. Genetic clonal diversity predicts progression to esophageal adenocarcinoma. Nature Genetics 38:468–473. , , , , , , et al.
- 2009. Molecular origins of cancer: molecular basis of colorectal cancer. New England Journal of Medicine 361:2449–2460. , and
- 2011. Spatial structure increases the waiting time for cancer. New Journal of Physics 13:11504. , , , and
- 1999. Pancolonic chromosomal instability precedes dysplasia and cancer in ulcerative colitis. Cancer Research 59:5148–5153. , , , , , , and
- 2003. The significance of unstable chromosomes in colorectal cancer. Nature Reviews Cancer 3:695–701. , , , and
- 2011. Relationship of extreme chromosomal instability with long-term survival in a retrospective analysis of primary breast cancer. Cancer Epidemiology Biomarkers Prevention 20:2183–2194. , , , , , , et al.
- 2010. Mutational heterogeneity in human cancers: origin and consequences. Annual Review of Pathology 5:51–75. , , and
- 2010. Cell selection as driving force in lung and colon carcinogenesis. Cancer Research 70:6797–6803. , , , and
- 2011. High DNA methylation pattern intratumoral diversity implies weak selection in many human colorectal cancers. PLoS ONE 6:e21657. , , , and
- 2006. The consensus coding sequences of human breast and colorectal cancers. Science 314:268–274. , , , , , , et al.
- 1997. Evolution of high mutation rates in experimental populations of E. coli. Nature 387:703–705. , , and
- 2007. p53 gain-of-function cancer mutants induce genetic instability by inactivating ATM. Nature Cell Biology 9:573–580. , , and
- 1997. Role of mutator alleles in adaptive evolution. Nature 387:700–702. , , , , , and
- 1999. Selection, the mutation rate and cancer: ensuring that the tail does not wag the dog. Nature Medicine 5:11–12. , and
- 1996. The mutation rate and cancer. Proceedings of the National Academy of Sciences of the United States of America 93:14800–14803. , , and
- 2008. Association between chromosomal instability and prognosis in colorectal cancer: a meta-analysis. Gut 57:941–950. , , and